Previous close | 1.7482 |
Open | 1.6320 |
Bid | 1.5974 x 123000 |
Ask | 1.6036 x 5500 |
Day's range | 1.5600 - 1.6396 |
52-week range | 1.2600 - 4.8200 |
Volume | |
Avg. volume | 2,795,383 |
Market cap | 444.842M |
Beta (5Y monthly) | 2.14 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.0800 |
Earnings date | 15 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 12.98 |
Reference is made to the stock exchange announcement by IDEX Biometrics ASA (the “Company”) on 15 May 2024 regarding a successful private placement of shares. By inadvertence, the announcement contained a slight error in the allocation of private placement shares between Tranche 1, as issued by the Board pursuant to an authorization to issue shares granted by the extraordinary general meeting dated 21 December 2023, and Tranche 2, to be issued subject to approval by an extraordinary general meet
IDEX Biometrics ASA held its annual general meeting on 16 May 2024. 95.3 million shares or 34% of the capital was represented at the meeting. All resolutions were passed as proposed by the board and nomination committee. The following board was elected at the meeting:Chair: Morten OpstadBoard members: Annika Olsson and Adriana Saitta. The minutes of the meeting will be available at the company’s web site, www.idexbiometrics.com, in due course. For further information contact: Marianne Bøe, Head
Aligned with the restructuring of IDEX’s organization to consolidate development and business operations to be located primarily in the UK and the EU/EEA, and to reduce costs, the nomination committee proposes that IDEX also reduces the size of the board of directors to a total of three. The nomination committee proposes that the following board shall be elected: Mr. Morten Opstad to continue for the second year of his term, in the role of chair of the board. Ms. Annika Olsson and Ms. Adriana Sa